Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BrainCool ABSTU:5YL 69 Days Payable is 126.90 as of Mar. 2026, which is 64% below its 10-year median of 357.26. GuruFocus rates STU:5YL with a GF Score™ of 69/100 and a GF Value™ of €0.09 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, BrainCool AB ranks better than 75.94% on this metric.
The historical rank and industry rank for BrainCool AB's Days Payable or its related term are showing as below:
STU:5YL'
s Days Payable Range Over the Past 10 Years
Min: 140.57 Med: 357.26 Max: 666.72
Current: 140.57
During the past 13 years, BrainCool AB's highest Days Payable was 666.72. The lowest was 140.57. And the median was 357.26.
STU:5YL's Days Payable is ranked better than 75.94% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs STU:5YL: 140.57
BrainCool AB's Days Payable
declined
from Mar. 2025 (144.38) to Mar. 2026 (126.90).
It may suggest that BrainCool ABaccelerated paying its suppliers.
BrainCool AB Days Payable Related Terms
BrainCool AB Days Payable Historical Data
* Premium members only.
The historical data trend for BrainCool AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BrainCool AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BrainCool AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BrainCool AB's Days Payable distribution charts can be found below:
* The bar in red indicates where BrainCool AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BrainCool AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BrainCool AB (STU:5YL) has a Days Payable of 126.90 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BrainCool AB and its competitors. This is 64% below median its historical median of 357.26. Over the past decade, BrainCool AB's Days Payable has ranged from 140.57 to 666.72. According to the industry distribution chart, BrainCool AB ranks #191 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is BrainCool AB's Days Payable too high?
BrainCool AB's current Days Payable of 126.90 is 64% below median its 10-year median of 357.26. Over the past 10 years, this metric has ranged from a low of 140.57 to a high of 666.72. The Medical Devices & Instruments industry median Days Payable is 67.85. BrainCool AB's value of 126.90 is 87% above this industry median. Based on the distribution chart, BrainCool AB ranks #191 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BrainCool AB has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BrainCool AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BrainCool AB ranks #191 out of 794 companies for Days Payable. This places BrainCool AB in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.85. BrainCool AB's value of 126.90 is 87% above this benchmark. Historically, BrainCool AB's own Days Payable has ranged from 140.57 to 666.72 over the past decade. While the company's 10-year median is 357.26 vs. the industry median of 67.85, BrainCool AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BrainCool AB's current Days Payable of 126.90 is 87% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BrainCool AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BrainCool AB's current Days Payable is 126.90, which is 64% below median its own 10-year median of 357.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrainCool AB stock overvalued right now?
Based on GuruFocus' analysis, BrainCool AB (STU:5YL) is currently considered Possible Value Trap. The stock's GF Value™ is €0.09, compared to a current price of €0.06 — trading 32.2% below its estimated fair value. The current Days Payable is 126.90, which is 64% below median its 10-year median of 357.26 and 87% above the Medical Devices & Instruments industry median of 67.85. BrainCool AB's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BrainCool AB (STU:5YL), the current Days Payable is 126.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BrainCool AB (STU:5YL) Overvalued in 2026?
Based on GuruFocus' analysis, BrainCool AB stock appears to be undervalued.
The current stock price of €0.06 is trading 32.2% below its estimated GF Value™ of €0.09.
GuruFocus considers BrainCool AB to be Possible Value Trap.
Key valuation signals for STU:5YL:
Days Payable: 126.90 (64% below median its 10-year median of 357.26)
GF Value™: €0.09 vs. price of €0.06 (32.2% below fair value)
Industry Position: 87% above the Medical Devices & Instruments median (#191 of 794)
No single metric tells the full story. See the STU:5YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BrainCool AB is a medical device company engaged in developing, marketing, and selling medical cooling systems for diseases like stroke, oral mucositis, migraine, and sudden cardiac arrest.
69GF Score
Get the complete analysis for STU:5YL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:5YL has been successfully added to your 
